Histometric and histopathological evaluation of the effect of Sertraline following cutaneous surgical trauma in the rat
Subject Areas :
Veterinary Clinical Pathology
سیامک Reyhani Rad
1
,
داریوش Mohajeri
2
,
Gh Mousavi
3
,
جواد Mahmoudi
4
,
علی Rezaie
5
,
سعید Yazdchi
6
1 - Islamic Azad University, Marand Branch, Marand, Iran
2 - Department of Pathobiology, Faculty of Veterinary Medicine, Islamic Azad University Tabriz Branch, Iran
3 - Department of Clinical Science, Faculty of Veterinary Medicine, Islamic Azad University Tabriz Branch, Iran
4 - Department of Pharmacology, Faculty of Specialized Veterinary Medicine, Islamic Azad University Science and Research Branch, Tehran, Iran
5 - Department of Clinical Science, Faculty of Veterinary Medicine, Islamic Azad University Tabriz Branch, Iran
6 - Islamic Azad University, Marand Branch, Marand, Iran
Received: 2009-01-19
Accepted : 2010-01-04
Published : 2009-08-23
Keywords:
Rat,
Wound healing,
Sertraline,
Abstract :
Selective serotonin reuptake inhibitors (SSRIs) are medications prescribed for the treatment of mood disorders including anxiety and depression. These drugs can prevent the development of inflammation and modulate interleukin and interferon production. It can be assumed from these features that the use of SSRIs could have a significant effect on wound healing. The aim of this experimental investigation was to evaluate the effect of sertraline on dermal wound healing in an animal model. In 60 Wistar rats, two circular wounds were made using a biopsy punch on the back of each animal. Rats were assigned to five groups of twelve animals each: Control group; Placebo group and experimental groups of the low, moderate and high dosage of sertraline ointment. Four rats of each group were sacrificed at 3, 7 and 15 days after operation. The shapes of the wounds were copied onto a transparent sheet, the figures were scanned, and the wound areas were calculated using scion image software and statistically analyzed. For histopathological studies, regenerated tissues were cut in the form of square pieces along with normal skin and stained with hematoxylin and eosin. The results show that sertraline treatment significantly reduced mean wound length. Morphmetrically, there were statistically significant differences between control, Placebo and experimental groups and there were significant histopathological differences between control, Placebo and experimental groups at the end of the study. The results of this study demonstrated that topical use of sertraline significantly improves healing of cutaneous wounds in the rat.
References:
رضایی، ع.، مهاجری، د.، دل آذر، ع.، بابالو، ز.، دستمالچی، ف. و تقی زاده جاهد، م. (1386): بررسی تأثیر عصاره گیاه فلومیس توبروزا در التیام زخم تجربی پوست در خرگوش، مطالعه مورفومتریک و هیستوپاتولوژیک، مجله دامپزشکی دانشگاه آزاد اسلامی واحد گرمسار، سال 3، شماره 4، صفحات: 194-185.
رضایی، ع.، دل آذر، ع.، مهاجری، د.، تقیزاده جاهد، م.، محمدنژاد، ص.، اشرفی، ع. و همکاران (1387): بررسی اثرات پماد عصاره Echinacea purpurea در مقایسه با پماد اکسید روی بعد از ترومای جراحی در پوست موش صحرایی، مطالعه هیستومتریک و هیستوپاتولوژیک، مجله علوم دارویی دانشکده داروسازی، دانشگاه تبریز، شماره 1، پیاپی 35، صفحات: 52-43.
علیزاده، ع.م.، محققی، م.ع.، خانیکی، م.، سعیدپور، خ.، خلیلوند، د. و غیاثی، ص. (1386): بررسی اثرات هیدروکسید آلومینیم بر ترمیم زخم پوستی در موش صحرایی. مجله علوم پزشکی ایران، دوره 14 شماره 56، صفحات: 124-117.
Bakish, D., Cavazzoni, P., Chudzik, J., Ravindran, A. and Hrdina, P.D. (1997): Effectes of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder. Biol. Psychol., 41: 184-190.
Farhani, R.M., Sadr, K., Rrad, J.S. and Mesqari, M. (2007): Fluoxetine enhances cutaneous wound healing in chronically stressed wistar rats. Adv. Skin. Wound Care, 20: 157-165.
Grewal, J.S., Mukhin, Y.V., Garnovskaya, M.N., Raymond, J.R. and Greene, E.L. (1996): Serotonin 5-HT2A receptor induces TGF-beta1 expression in mesangial cells via ERK: prolifrative and fibrotic signals. Am. J. physiol., 276: 922-930.
Jian, B., Xu, J., Connolly, J., Savani, R.C.,Narula, N., Liang, B., et al.(2002): Serotonin mechanisms in heart valve disease I; serotonin – induced upregulation of transforming growth factor – beta 1 via G – protein signal transduction in aortic valve interstitial cells. Am. J. Pathol., 161: 2111-2121.
Kasho, M., Sakai, M., Sasahara, T., Anami, Y., Matsumura, T., Takemura, T., et al. (1998): Serotonin enhances the production of type IV collagen by human mesangial cells. kidney Int., 54: 1083-1092.
Krasowska, D., Szymanek, M., Schwartz, R.A. and Mys´lin´ski, W. (2007): Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors. J. Am. Acad. Dermatol., 56: 848-853.
Kubera, M., Lin, A.H., Kenis, G., Bosmans, E., van Bockstaele, D. and Maes, M. (2001): Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio. J. Clin. Psychopharmacol., 21: 199-206.
Maes, M. (2001): The immunoregulatory effects of antidepressants. Hum Psychopharmacol., 16: 95-103.
Malberg, J.E., Eisch, A.J., Nestler, E.J. and Duman, R.S. (2000): Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci., 20: 9104-9110.
Malinin, A., Oshrine, B. and Serebruany, V. (2004): Treatment with selective serotonin reuptake inhibitors for enhancing wound healing, Medical Hypotheses, 63: 103-109.
Michelson, D., Misiewicz-Poltorak, B., Raybourne, R.B., Gold, P.W. and Sternberg, E.M. (1994): Imipramine reduces the local inflammatory response to carrageenin. Agents Actions, 42: 25-28.
Mossner, R., Daniel, S., Schmitt, A., Albert, D. and Lesch, K.P. (2001): Modulation of serotonin transporter function by interleukin-4. Life Sci., 68: 873-880.
Mullaney, P. and Curren, B. (1991): Fibroblast and endothelial outgrowth from human tenon`s explants; inhibition of fibroblast growth by 5HT receptor antagonism. Res. commun. chem. patol. pharmacol., 74: 201-213.
Phillips, O.M., Wood, K.M. and Williams, D.C. (1998): Kinetics of the interaction of sertraline with the human platelet plasma membrane 5-hydroxytryptamine carrier. Eur. J. pharmacol., 146: 299-306.
Sereburany, V.L., Gurbel, P.A. and O`Connor, C.M. (2001): Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors. Pharm. Res., 43: 4534-62.
Sereburany, V.L., O`Connor, C.M. and Gurbel, P.A. (2001): Effect of selective serotonin reuptake inhibitors on platelets in patients with coronary artery disease. Am. J. Cardiol., 87: 1398-1400.
Serebruany, V.L., Glassman, A.H., Malinin, A.L., Krishnan, R., Finkel, M., Nemeroff, C. and et al. (2003): Effects of Zoloft on platelet/endothelial biomarkers in depressed patients after acute coronary events: Sertraline antidepressant heart attack randomized trial (SADHART platelet substudy). Circulation, 108: 939-944.
Yang, M., Srikiatkhachorn, A., Anthony, M. and Chong, B.H. (1996): Serotonin stimulates megakaryocytopoiesis via the 5-HT2 receptor. Blood Coagul. Fibrinolysis, 7: 127-33.
Young, M.R. and Matthews, J.P. (1995): Serotonin regulation of T-cell subpopulations and of macrophage accessory function, 84: 148-152.
Zayed, M.A., Hawash, M.F., Fahmey, M.A. and El-Habeeb, A.A. (2007): Structure investigation of sertraline drug and its iodine product using mass spectrometry, thermal analyses and MO-calculations, Spectrochimica Acta. Part. A., 68: 970-978.